Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arv-471
2. Arv-471 (protac)
3. Wc1u3r1ymi
4. 2229711-68-4
5. Arv471
6. (s)-3-(5-(4-((1-(4-(rel-(1r,2s)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
7. 2614417-52-4
8. Vepdegestrant [inn]
9. Starbld0006985
10. Unii-wc1u3r1ymi
11. Arv 471
12. Arv 471 [who-dd]
13. Chembl5095210
14. Schembl20211870
15. Akos040757430
16. Ms-31245
17. Hy-138642
18. Cs-0159885
19. En300-37105519
20. (2(1)r,2(2)s,8(3)s)-2-hydroxy-2(1),2(2),2(3),2-tetrahydro-7(5,2)-isoindola-6(1,4)-piperazina-4(1,4),8(3)-dipiperidina-2(2,1)-naphthalena-1(1),3(1,4)-dibenzenaoctaphane-7(1),8(2),8(7(3)h)-trione
21. (3s)-3-(5-{4-[(1-{4-[(1r,2s)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl]phenyl}piperidin-4-yl)methyl]piperazin-1-yl}-1-oxo-2,3-dihydro-1h-isoindol-2-yl)piperidine-2,6-dione
22. (s)-3-(5-(4-((1-(4-((1r,2s)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
23. 2,6-piperidinedione, 3-(1,3-dihydro-1-oxo-5-(4-((1-(4-((1r,2s)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl)phenyl)-4-piperidinyl)methyl)-1-piperazinyl)-2h-isoindol-2-yl)-, (3s)-
Molecular Weight | 723.9 g/mol |
---|---|
Molecular Formula | C45H49N5O4 |
XLogP3 | 6.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 96.4 |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 1310 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
31
PharmaCompass offers a list of Vepdegestrant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vepdegestrant manufacturer or Vepdegestrant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vepdegestrant manufacturer or Vepdegestrant supplier.
PharmaCompass also assists you with knowing the Vepdegestrant API Price utilized in the formulation of products. Vepdegestrant API Price is not always fixed or binding as the Vepdegestrant Price is obtained through a variety of data sources. The Vepdegestrant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vepdegestrant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vepdegestrant, including repackagers and relabelers. The FDA regulates Vepdegestrant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vepdegestrant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vepdegestrant supplier is an individual or a company that provides Vepdegestrant active pharmaceutical ingredient (API) or Vepdegestrant finished formulations upon request. The Vepdegestrant suppliers may include Vepdegestrant API manufacturers, exporters, distributors and traders.
Vepdegestrant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vepdegestrant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vepdegestrant GMP manufacturer or Vepdegestrant GMP API supplier for your needs.
A Vepdegestrant CoA (Certificate of Analysis) is a formal document that attests to Vepdegestrant's compliance with Vepdegestrant specifications and serves as a tool for batch-level quality control.
Vepdegestrant CoA mostly includes findings from lab analyses of a specific batch. For each Vepdegestrant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vepdegestrant may be tested according to a variety of international standards, such as European Pharmacopoeia (Vepdegestrant EP), Vepdegestrant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vepdegestrant USP).